-
Crisaborole
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Crisaborole I-Atopic Dermatitis kunye ne-Eczema Pfizer -
Etelcacetide
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Etelcacetide I-hyperparathyroidism yesibini (HPT) Amgen -
Abemaciclib
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Abemaciclib Umhlaza wamabele, unyango lomhlaza wedlala lobudoda Eli Lily Dec.15,2029 -
Deucracitinib
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Deucracitinib Anti plaque psoriasis Inkampani yaseBristol-Myers Squibb Nov.07,2033 -
Apremilast
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Apremilast isifo samathambo Celgene -
I-Remdesivir
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) I-Remdesivir Ii-Antivirus (Ebola, Covid-19) eGiliyadi -
Paxlovid
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Paxlovid I-covid 19 Pfizer -
Pomalidomide
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Pomalidomide Iyeza le-Oncology Celgene -
I-Nirmatrelvir
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) I-Nirmatrelvir I-3C-NjengeProtease (3CLPRO) Inhibitor kunye ne-SARS-Cov-2 Mpro Inhibitor -
I-Elrombopag
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) I-Elrombopag I-ITP kunye ne-Aplastic anemia Novartis & GSK UCanzibe. 20, 2023 -
I-Ruxolitinib
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) I-Ruxolitinib I-Myelofibrosis Novartis Nge-6 kaJulayi, 2024 -
Crisaborole
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Crisaborole I-Atopic Dermatitis kunye ne-Eczema Pfizer NgoJuni 11, 2026